应用Kaiser评分提高诊断性乳腺X线摄影可疑病灶的診斷準確性:轉診至乳腺MR成像的研究
回顾性评估3623例因乳腺X线摄影(MG)可疑或不确定病灶而转诊行乳腺MR成像(MRM)的病例,由三名不同经验阅片者按Kaiser评分树状分类系统评分1–11分。183个肿块和133个非肿块强化病灶中,良性95个、恶性221个,总AUC为0.796(肿块0.851、非肿块强化0.715)。以评分<5替代<4排除恶性可正确识别100%良性病灶,以>8为高阈值纳入恶性时特异度80%、阳性似然比3。
要点
- 对MG可疑病灶行MRM时,Kaiser评分总AUC为0.796,肿块强化AUC 0.851高于非肿块强化0.715。
- 以评分<5替代<4排除恶性可正确识别100%良性病灶。
- 以评分>8纳入恶性时正确识别59.7%病灶,特异度80%,阳性似然比3。
关键影像表现/征象
- 183个肿块强化病灶和133个非肿块强化(NME)病灶中,良性95个、恶性221个。
- Kaiser评分上调202个病灶,其中77%预测正确;下调28个病灶,其中60.8%预测正确。
诊断标准与关键数值
- 总AUC 0.796,肿块强化AUC 0.851,非肿块强化AUC 0.715。
- 以评分<5替代<4排除恶性,可正确识别100%良性病灶。
- 以评分>8纳入恶性,正确识别59.7%病灶,特异度80%,阳性似然比3。
- 应用Kaiser评分正确下调60.8%(17/28)病灶,从而避免这些病灶的活检。
临床应用与阅片要点
- 对MG可疑或不确定病灶行MRM时,可按Kaiser评分树状分类系统评分1–11分辅助判断恶性可能性。
- 以评分<5作为排除恶性的阈值可正确识别100%良性病灶,以>8作为纳入恶性的高阈值时特异度80%、阳性似然比3。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
INTRODUCTION: We aimed to interpret MR mammography (MRM) using the Kaiser scores for equivocal or inconclusive lesions on mammography (MG).
METHODS: Retrospective IRB-approved evaluation of 3623 MG for which MRM was deployed as a problem-solving tool, after inclusion-exclusion criteria were met. Three readers with different levels of experience assigned a final score from 1 to 11 based on the previously established tree classification system. Area under the curve (AUC) derived from receiver operating characteristic (ROC) analysis was used to determine the overall diagnostic performance for all lesions and separately for mass and non-mass enhancement. Sensitivity, specificity, and likelihood ratio values were obtained at different cut-off values of >4, > 5, and > 8 to rule in and rule out malignancy.
RESULT: Histopathology of 183 mass and 133 non-mass enhancement (NME) lesions show benign etiology in 95 and malignant in 221. The AUC was 0.796 [0.851 for mass and 0.715 for NME]. Applying the Kaiser score upgraded 202 lesions with correct prediction in 77 %, and downgraded 28 lesions with correct prediction in 60.8 %. Using a score <5 instead of <4 to rule out malignancy improved our diagnostic ability to correctly identify 100 % benign lesions. Applying Kaiser score correctly downgraded 60.8 % (17/28) lesions; thus avoiding biopsies in these. Using a high cut-off value>8 to rule-in malignancy, we correctly identified 59.7 % of lesions with 80 % specificity and positive likelihood ratio of 3.
CONCLUSION: The Kaiser score has clinical translation benefits when used as a problem-solving tool for inconclusive MG findings.
引用
- Jajodia A, Sindhwani G, Pasricha S, et al. Application of the Kaiser score to increase diagnostic accuracy in equivocal lesions on diagnostic mammograms referred for MR mammography. Eur J Radiol. 2020. PMID: 33290973. doi:10.1016/j.ejrad.2020.109413
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。